PDCD5 expression predicts a favorable outcome in patients with hepatocellular carcinoma

International Journal of Oncology

Volumn 43, Issue 3, 2013, Pages 821-830

  Fu, Da Zhi ^a   Cheng, Ying ^a   He, Hui ^a   Liu, Hai Yang ^a   Liu, Yong Feng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Hepatocellular carcinoma; PDCD5; Proteasome

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; MESSENGER RNA; PROGRAMMED CELL DEATH 5; PROTEIN; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL TIME; UPREGULATION;

AGED; ALPHA-FETOPROTEINS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LEUPEPTINS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84880644671     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1993     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 6: 69-90, 2011.
2. Bosch FX, Ribes J, Diaz M, et al: Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-S16, 2004.
3. Perz JF, Armstrong GL, Farrington LA, et al: The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45: 529-538, 2006.
4. Liu H, Wang Y, Zhang Y, et al: TFAR19, a novel apoptosis related gene cloned from human leukemia cell line TF21, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 254: 203-210, 1999.
5. Spinola M, Meyer P, Kammerer S, et al: Association of the PDCD5 locus with lung cancer risk and prognosis in smokers. J Clin Oncol 24: 1672-1678, 2006.
6. Liu D, Feng Y, Cheng Y, et al: Human programmed cell death 5 protein has a helical-core and two dissociated structural regions. Biochem Biophys Res Commun 318: 391-396, 2004.
7. Hedenfalk I, Duggan D, Chen Y, et al: Gene-expression profiles in hereditary breast cancer. N Engl J Med 344: 539-548, 2001.
8. Yang Y, Zhao M, Li W, et al: Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells. Apoptosis 11: 993-1001, 2006.
9. Li H, Wang Q, Gao F, et al: Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas. Oncol Rep 20: 573-579, 2008.
10. Ruan G, Qin Y, Chen S, et al: Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia. Leuk Res 30: 1159-1165, 2006.
11. Feng YM, Zhang YM and Jing GZ: Soluble expression in Escherichia coli, purification and characterization of a human TF-1 cell apoptosis-related protein TFAR19. Protein Expr Purif 25: 323-329, 2002.
12. Wang J, Guan Z and Ge Z: Plasma and synovial fluid programmed cell death 5 (PDCD5) levels are inversely associated with TNF-α and disease activity in patients with rheumatoid arthritis. Biomarkers 18: 155-159, 2013.
13. Wang Y, Wang GH and Zhang QY: Determination of PDCD5 in peripheral blood serum of cancer patients. Chin J Cancer Res 23: 224-228, 2011.
14. Xu L, Chen Y, Song Q, et al: PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis. Neoplasia 11: 345-354, 2009.
15. Xu L, Hu J, Zhao Y, et al: PDCD5 interacts with p53 and functions as a positive regulator in the p53 pathway. Apoptosis 17: 1235-1245, 2012.
16. Li H, Zhang X, Song X, et al: PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway. Cancer Biol Ther 13: 822-830, 2012.
17. Han XR, Sun Y and Bai XZ: The antitumor role and mechanism of integrated and truncated PDCD5 proteins in osteosarcoma cells. Cell Signal 24: 1713-1721, 2012.
18. Berman DM, Karhadkar SS, Maitra A, et al: Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425: 846-851, 2003.
19. Markaryan A, Nelson EG, Tretiakova M, et al: Technical report: immunofluorescence and TUNEL staining of celloidin embedded human temporal bone tissues. Hear Res 241: 1-6, 2008.
20. Fekete MR, McBride WH and Pajonk F: Anthracyclines, proteasome activity and multi-drug-resistance. BMC Cancer 5: 114, 2005.
21. Xu XR, Huang J, Xu ZG, et al: Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding non-cancer liver. Proc Natl Acad Sci USA 98: 15089-15094, 2001.
22. Chen C, Zhou H, Xu L, et al: Prognostic significance of downregulated expression of programmed cell death 5 in chondrosarcoma. J Surg Oncol 102: 838-843, 2010.
23. Dudich E, Semenkova L, Gorbatova E, et al: Growth - regulative activity of human alpha-fetoprotein for different types of tumor and normal cells. Tumour Biol 19: 30-40, 1998.
24. Wang XW and Xu B: Stimulation of tumor - cell growth by alpha-fetoprotein. Int J Cancer 75: 596-599, 1998.
25. Wang JF, Guan ZP, Zhang SL, et al: Programmed cell death 5 correlates with disease activity and interleukin-17 in serum and synovial fluid of rheumatoid arthritis patients. Chin Med J (Engl) 126: 296-299, 2013.
26. Wang Y, Li X, Wang L, et al: An alternative form of paraptosis like cell death, triggered by TAJ/TROYand enhanced by PDCD5 overexpression. J Cell Sci 117: 1525-1532, 2004.
27. Chen Y, Sun R, Han W, et al: Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis? FEBS Lett 509: 191-196, 2001.
28. Rui M, Chen YY, Zhang YM, et al: Transfer of anti-TFAR19 monoclonal antibody into HeLa cells by in situ electroporation can inhibit the apoptosis. Life Sci 71: 1771-1778, 2002.
29. Chen LN, Wang Y, Ma DL, et al: Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression. Apoptosis 11: 101-111, 2006.
30. Salvi M, Xu D, Chen Y, et al: Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cells. Biochem Biophys Res Commun 387: 606-610, 2009.
31. An L, Zhao X, Wu J, et al: Involvement of autophagy in cardiac remodeling in transgenic mice with cardiac specific over-expression of human programmed cell death 5. PLoS One 7: e30097, 2012
32. Adams J: The development of proteasome inhibitors as anticancer drugs. Cancer Cell 5: 417-421, 2004.
33. Wu WK, Cho CH, Lee CW, et al: Proteasome inhibition: a new therapeutic strategy to cancer treatment. Cancer Lett 293: 15-22, 2010.